IN2014DN09963A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN09963A IN2014DN09963A IN9963DEN2014A IN2014DN09963A IN 2014DN09963 A IN2014DN09963 A IN 2014DN09963A IN 9963DEN2014 A IN9963DEN2014 A IN 9963DEN2014A IN 2014DN09963 A IN2014DN09963 A IN 2014DN09963A
- Authority
- IN
- India
- Prior art keywords
- cancer
- treatment
- relates
- soluble peptide
- krfyvvmwkk
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 108010017447 4N1K peptide Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12305636 | 2012-06-06 | ||
| PCT/EP2013/061727 WO2013182650A1 (en) | 2012-06-06 | 2013-06-06 | Method and pharmaceutical composition for use in the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN09963A true IN2014DN09963A (enrdf_load_stackoverflow) | 2015-08-14 |
Family
ID=48669879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN9963DEN2014 IN2014DN09963A (enrdf_load_stackoverflow) | 2012-06-06 | 2013-06-06 |
Country Status (8)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2968536B1 (en) * | 2013-03-13 | 2023-06-28 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Methods for modulating chemotherapeutic cytotoxicity |
| EP3243522A1 (en) * | 2016-05-10 | 2017-11-15 | Université Pierre et Marie Curie (Paris 6) | Agonist agents of cd47 inducing programmed cell death and their use in the treatments of diseases associated with defects in programmed cell death |
| EP3454884B1 (en) | 2016-05-10 | 2023-07-12 | Sorbonne Université | Agents that activate cd47 and their use in the treatment of inflammation |
| ES2908729T3 (es) * | 2016-05-10 | 2022-05-03 | Inst Nat Sante Rech Med | Nuevos compuestos y uso farmacéutico de los mismos en el tratamiento del cáncer |
| CN107703109B (zh) * | 2016-08-08 | 2021-01-15 | 华东理工大学 | 二维硫化钼多肽复合材料及其在靶向cd47癌症标记中的应用 |
| US12331320B2 (en) | 2018-10-10 | 2025-06-17 | The Research Foundation For The State University Of New York | Genome edited cancer cell vaccines |
| EP3650036A1 (en) * | 2018-11-06 | 2020-05-13 | Sorbonne Universite | Synthetic peptides inducing immunogenic cell death |
| US20220160812A1 (en) * | 2019-05-22 | 2022-05-26 | Cytopharma Gmbh | A pharmaceutically active substance |
| CN116831988A (zh) * | 2023-06-13 | 2023-10-03 | 南京鼓楼医院 | 一种载肽模拟物pkhb1的脂质体眼用制剂及其制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990005183A1 (en) | 1988-10-31 | 1990-05-17 | Immunex Corporation | Interleukin-4 receptors |
| AU651596B2 (en) | 1990-06-05 | 1994-07-28 | Immunex Corporation | Type II interleukin-1 receptors |
| US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| AU684348B2 (en) | 1994-06-07 | 1997-12-11 | Nihon Medi-Physics Co., Ltd. | Tumor affinity peptide, and radioactive diagnostic agent and adioactive therapeutic agent containing the peptide |
| US5610271A (en) * | 1995-06-07 | 1997-03-11 | Torrey Pines Institute For Molecular Studies | Kappa receptor selective opioid peptides |
| US6074849A (en) | 1995-07-19 | 2000-06-13 | Genetics Institute, Inc. | Polynucleotides encoding human CTLA-8 related proteins |
| EP0969855B1 (en) * | 1996-11-27 | 2006-02-08 | Boston Heart Foundation, Inc. | Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| US6579520B2 (en) | 1998-05-15 | 2003-06-17 | Genentech, Inc. | IL-17 related mammalian cytokine polypeptides (IL-17E) |
| US6569645B2 (en) | 1999-05-14 | 2003-05-27 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
| AU2001265082A1 (en) * | 2000-05-26 | 2001-12-11 | Beth Israel Deaconess Medical Center | Thrombospondin-1 type 1 repeat polypeptides |
| WO2006089209A2 (en) * | 2005-02-17 | 2006-08-24 | The Board Of Trustees Of The Leland Stanford Junior University | Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby |
| JP2009013142A (ja) | 2007-07-09 | 2009-01-22 | Kyoto Univ | 徐放用メソポーラスシリカ |
| JP5661988B2 (ja) | 2008-02-26 | 2015-01-28 | 株式会社ペプタイドドア | ムスカリンレセプター活性化剤及びペプチド |
-
2013
- 2013-06-06 EP EP13730146.1A patent/EP2858660B1/en not_active Not-in-force
- 2013-06-06 DK DK18192533.0T patent/DK3434276T3/da active
- 2013-06-06 JP JP2015515526A patent/JP2015520178A/ja active Pending
- 2013-06-06 CN CN201380029870.5A patent/CN104519898A/zh active Pending
- 2013-06-06 WO PCT/EP2013/061727 patent/WO2013182650A1/en active Application Filing
- 2013-06-06 EP EP18192533.0A patent/EP3434276B1/en active Active
- 2013-06-06 ES ES18192533T patent/ES3009438T3/es active Active
- 2013-06-06 IN IN9963DEN2014 patent/IN2014DN09963A/en unknown
- 2013-06-06 US US14/406,091 patent/US9198949B2/en active Active
-
2015
- 2015-10-05 US US14/874,657 patent/US20160039908A1/en not_active Abandoned
-
2017
- 2017-08-28 US US15/687,692 patent/US20170362302A1/en not_active Abandoned
- 2017-11-22 JP JP2017224767A patent/JP2018057394A/ja active Pending
-
2018
- 2018-10-16 US US16/161,931 patent/US10759843B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018057394A (ja) | 2018-04-12 |
| ES3009438T3 (en) | 2025-03-26 |
| US20160039908A1 (en) | 2016-02-11 |
| EP2858660A1 (en) | 2015-04-15 |
| EP3434276A1 (en) | 2019-01-30 |
| US20170362302A1 (en) | 2017-12-21 |
| US10759843B2 (en) | 2020-09-01 |
| US20150126456A1 (en) | 2015-05-07 |
| WO2013182650A1 (en) | 2013-12-12 |
| US20190135898A1 (en) | 2019-05-09 |
| US9198949B2 (en) | 2015-12-01 |
| EP3434276B1 (en) | 2024-10-30 |
| EP2858660B1 (en) | 2018-09-05 |
| JP2015520178A (ja) | 2015-07-16 |
| DK3434276T3 (da) | 2025-01-20 |
| CN104519898A (zh) | 2015-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN09963A (enrdf_load_stackoverflow) | ||
| MX360208B (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| MX363136B (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| MX360211B (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| MX340014B (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| MX2012008998A (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| MX2012009000A (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| MX340016B (es) | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. | |
| NZ587105A (en) | Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage | |
| BR112014019901A8 (pt) | Proteínas de fator viii recombinante | |
| NZ601818A (en) | Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancers | |
| EA033399B1 (ru) | Аналоги глюкагона с повышенной растворимостью и/или стабильностью и их применение | |
| WO2017009843A3 (en) | Compositions, articles of manufacture and methods for treating cancer | |
| BR112012029975A2 (pt) | peptídeo como medicamento, em particular para o tratamento do câncer. | |
| NZ629843A (en) | Identification of channelrhodopsin-2 (chop2) mutations and methods of use | |
| WO2016004906A3 (zh) | 一种肿瘤血管阻断剂多肽、基因、表达载体及其应用 | |
| NZ708990A (en) | Method for activating helper t cell | |
| SG10201407944TA (en) | Imp-3 oligopeptides and vaccines including the same | |
| NZ609916A (en) | Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof | |
| RU2015112625A (ru) | Пептид, применение пептида для лечения сердечно-сосудистых заболеваний, нуклеотидная последовательность, вектор экспрессии, хозяйская клетка, фармацевтическая композиция | |
| EA033437B9 (ru) | Fc-гамма-рецептор iib и его применение для лечения или предупреждения воспалительных и/или аутоиммунных заболеваний | |
| NZ609474A (en) | Fviii peptides for immune tolerance induction and immunodiagnostics | |
| NZ603442A (en) | Treatment of proliferative diseases | |
| EP3925968A3 (en) | Hsp70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell | |
| NZ709120A (en) | Beta-hexosyl-transferases and uses thereof |